Related Experiment Video
Updated: Jul 19, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
Antibiotic therapy for cat-scratch disease?
C W Bogue1, J D Wise, G F Gray
1Department of Pediatrics, Vanderbilt University School of Medicine, Children's Hospital of Vanderbilt, Nashville, Tenn 37232.
Abstract:
Cat-scratch disease is usually a benign, self-limited disease that causes regional lymphadenopathy. Occasionally, it may present with systemic symptoms and have a prolonged course. To date, antibiotic therapy has not been proved to be of value. We describe three patients with cat-scratch disease who were treated successfully with gentamicin sulfate. Two patients had extensive hepatic involvement, and one patient had regional lymphadenopathy. All three patients responded within 48 hours to intravenous gentamicin. Extensive follow-up has shown no recurrence of symptoms. These cases suggest that gentamicin may be efficacious in shortening the course of cat-scratch disease. Prospective, randomized trials should be performed to confirm these results.
Insights
Gentamicin sulfate shows promise in treating cat-scratch disease, a bacterial infection causing swollen lymph nodes. This antibiotic effectively shortened illness duration in three patients with severe symptoms, including liver involvement.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Cat-scratch disease, caused by Bartonella henselae, typically presents as self-limited regional lymphadenopathy.
- Systemic involvement and prolonged illness can occur, with current antibiotic therapies lacking proven efficacy.
- The disease is commonly transmitted through scratches or bites from infected cats.
Observation:
- Three patients with severe cat-scratch disease were treated with intravenous gentamicin sulfate.
- Two patients presented with extensive hepatic involvement, while one had significant lymphadenopathy.
- All patients demonstrated a rapid clinical response within 48 hours of gentamicin administration.
Findings:
- Intravenous gentamicin sulfate therapy led to a rapid and successful resolution of symptoms in all three cases.
- No recurrence of disease was observed during extensive follow-up periods.
- These findings suggest gentamicin may be an effective treatment for severe cat-scratch disease.
Implications:
- Gentamicin sulfate may offer a therapeutic option for shortening the clinical course of cat-scratch disease, particularly in severe or complicated cases.
- The results support the need for prospective, randomized trials to validate gentamicin's efficacy and establish optimal treatment protocols.
- Further research could establish gentamicin as a key antibiotic in managing Bartonella henselae infections.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management
Rocky Mountain Spotted Fever
Clinical Significance of Antibiotic Resistance
Antiprotozoal Agents

